BioSpace News Archive

InCrowd, the pioneer of real-time, high-quality, primary market intelligence for the life science industry, has appointed Joseph Baldini to lead its engineering function as InCrowd continues to broaden its technological capabilities and grow the market for mobile-first, on-demand market insights.

BioSig Technologies, Inc. announced that Zachariah P. Zachariah, M.D., a Florida-based cardiologist, joined the Advisory Board of the Company..

Cyft Inc., a health care analytics company dedicated to helping organizations succeed in value-based care, has announced the launch of the Serious Illness Performance Collaborative.

APLIX today announced the commercialization of new inter-mold® low profile hooks for medical and orthopedic applications.

As drug companies race to find treatments and vaccines to combat the novel coronavirus, QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced the readiness of an access restricted bioanalysis lab prepared to analyze COVID-19 clinical trial samples.

Verdeca, a joint venture between Arcadia Biosciences Inc. and Bioceres Crop Solutions Corp., will be showcasing pre-commercial soybean varieties carrying the drought tolerant HB4® trait to more than 150,000 South American growers at Expoagro 2020, being held March 10-13 in San Nicolas, Argentina.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the fourth quarter and full year ended December 31, 2019 and reviewed recent business progress.

Impulse Dynamics, a company dedicated to improving the lives of people with heart failure and developer of the innovative CCM™ therapy delivered by the Optimizer® Smart System, today announced the appointment of Ishu Rao, M.D., as medical director.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that it will release fourth quarter and full year 2019 financial results before the market opens on Thursday, March 19, 2020.

Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced a partnership with Imprivata®, the digital identity company for healthcare, to integrate Imprivata Medical Device Access – streamlined, secure authentication to medical devices for clinical users – into Masimo’s Hospital Automation solutions, featuring the Root® Patient Monitoring and Connectivity Platform and Iris Gateway®.